Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition

Abstract Background Thrombotic microangiopathy (TMA) is a potentially organ and life-threatening condition affecting patients with multiple myeloma (MM). Cases of proteasome inhibitor-induced TMA and specifically carfilzomib-induced TMA have been rarely reported and standards for diagnostic workup a...

Full description

Bibliographic Details
Published in:	BMC Nephrology
Main Authors:	Lorenzo Catanese, Katharina Link, Harald Rupprecht
Format:	Article
Language:	English
Published:	BMC 2023-06-01
Subjects:	Case report Thrombotic microangiopathy (TMA) Multiple myeloma (MM) Carfilzomib Eculizumab
Online Access:	https://doi.org/10.1186/s12882-023-03228-9

Similar Items

Effective Management of Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma Using Eculizumab
by: Jennifer Kim, et al.
Published: (2025-06-01)

Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature Review
by: Federica Pallotti, et al.
Published: (2022-12-01)

Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review
by: Andrea Ceglédi, et al.
Published: (2024-12-01)

Carfilzomib‐Induced Thrombotic Microangiopathy—Two Case Reports
by: Irene Attucci, et al.
Published: (2024-10-01)

Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report
by: Mihriban İnözü, et al.
Published: (2022-12-01)

Posttransplant thrombotic microangiopathy: Unraveling a mystery
by: Mohammed Fahad Khan, et al.
Published: (2024-01-01)

Posttransplant thrombotic microangiopathy: Unraveling a mystery
by: Mohammed Fahad Khan, et al.
Published: (2024-01-01)

Thrombotic Microangiopathy with Complement Factor H Gene Mutations Unassociated with Atypical Hemolytic Uremic Syndrome
by: Yesim Oymak, et al.
Published: (2015-07-01)

The outcome of thrombotic microangiopathy in kidney transplant recipients
by: Kanza Haq, et al.
Published: (2024-11-01)

Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option
by: Elena Román, et al.
Published: (2017-09-01)

Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy
by: Robert C. Sterner, et al.
Published: (2022-04-01)

Association of thrombotic microangiopathy with interferon therapy for hepatitis B: a case report
by: Shan Wei, et al.
Published: (2024-07-01)

The conundrum of postpartum thrombotic Microangiopathy: case report and considerations for management
by: Katharina Artinger, et al.
Published: (2019-03-01)

Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
by: Fei-Fei Chen, et al.
Published: (2023-12-01)

Thrombotic microangiopathy multidisciplinary assessment team: demographics, final diagnosis, treatment, and outcomes
by: Matthew Nguyen, et al.
Published: (2025-09-01)

“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-04-01)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal OutcomesPlain Language Summary
by: Natalja Haninger-Vacariu, et al.
Published: (2023-07-01)

Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy
by: Gianluigi Ardissino, et al.
Published: (2022-07-01)

Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature
by: Ratna Acharya, et al.
Published: (2024-05-01)

A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy
by: Rachael D. Wright, et al.
Published: (2020-06-01)

Plasminogen mutation–associated thrombotic microangiopathy and role of anticoagulation: a single institution case series
by: Shreya Agarwal, et al.
Published: (2025-08-01)

Case report: Successful treatment of renal-limited thrombotic microangiopathy secondary to chronic lymphocytic leukemia
by: Kristina Nasr, et al.
Published: (2024-08-01)

New in the differential diagnosis of different variants of thrombotic microangiopathies in obstetrics
by: T. V. Kirsanova, et al.
Published: (2021-04-01)

Early Thrombotic Microangiopathy After ABO-Incompatible Living Donor Kidney Transplantation
by: Dominique Bertrand, et al.
Published: (2025-03-01)

Drug-induced de novo thrombotic microangiopathy diagnosed 2 years after renal transplantation: a case report and literature review
by: Keisuke Ozaki, et al.
Published: (2023-01-01)

Pseudo-Thrombotic Microangiopathy (Pseudo-TMA): a rare manifestation of vitamin B12 deficiency in a child
by: Mohd Arif, et al.
Published: (2025-06-01)

Eculizumab treatment in a patient with hematopoietic stem cell transplantation-associated thrombotic microangiopathy and steroid-refractory acute graft versus host disease
by: Cristina Fernández, et al.
Published: (2015-12-01)

Transplant-associated Thrombotic Microangiopathy: An Enigma Treated with Eculizumab
by: S. Ravitej, et al.
Published: (2024-10-01)

Thrombotic microangiopathy associated with Valproic acid toxicity
by: Sean A. Hebert, et al.
Published: (2017-08-01)

Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)

Thrombotic microangiopathy in children: Redefining hemolytic uremic syndrome, thrombotic thrombocytopenic purpura and related disorders
by: Mamta Manglani, et al.
Published: (2024-03-01)

Thrombotic microangiopathy associated with lenvatinib therapy
by: Macarena Contreras Angulo, et al.
Published: (2023-04-01)

Time course of organ and hematological response to complement blockage in transplant-associated thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
by: Tatiana A. Rudakova, et al.
Published: (2025-03-01)

Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy
by: Idris Boudhabhay, et al.
Published: (2021-06-01)

Use of Eculizumab in Transplant-Associated Thrombotic Microangiopathy in a Patient With Polycystic Kidney Disease Immediately Post–Kidney Transplant: A Case Report
by: Amandeep Godara, et al.
Published: (2020-09-01)

Acute Kidney Injury Secondary to Pegylated Liposomal Doxorubicin-Associated Renal-limited Thrombotic Microangiopathy
by: Tarek S. Karam, et al.
Published: (2025-05-01)

Thrombotic microangiopathy (TMA) associated with pregnancy: role of the clinical laboratory in differential diagnosis
by: Ramos Mayordomo Patricia, et al.
Published: (2024-04-01)

Three shades of black - secondary thrombotic microangiopathy
by: Rhituparna Das, et al.
Published: (2022-01-01)

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports
by: Ping-Chih Hsu, et al.
Published: (2023-01-01)

Thrombotic microangiopathy after kidney transplantion
by: Mohammad Sami Tahseen, et al.
Published: (2023-12-01)